PROTO LABS INC
PRLBNYSE🏆 #1642 by market capEarnings Oct 29US Equity
$90.45▲ $0.80 (+0.88%)
Market closed · at close1h—
24h▲ 0.9%
7d▲ 0.3%
14d▲ 26.8%
30d▲ 21.0%
1y▲ 89.7%
🏦Market Cap
$2.15B
Small Cap
📈Revenue Growth (YoY)
+10.2%
Healthy
📊Gross Margin
45.4%
Healthy
💵FCF Margin
10.1%
Healthy
⚖️P/S Ratio
3.8x
Fair
Otter Score
64
Fair
📊
Analyst Ratings
Price
$90.45
Total
17
Raised
0
Lowered
7
Avg PT
$87.00
H / L
$87 / $87
| Institution | Action | Rating | Date |
|---|---|---|---|
Benchmark | Reiterated | Buy | 2026-07-06 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-08-01 |
Needham | Reiterated | Hold | 2025-02-07 |
Craig-Hallum | Reiterated | Hold | 2024-11-04 |
Lake Street | Reiterated | Buy | 2023-08-07 |
Berenberg | Downgraded | Buy → Hold | 2020-01-23 |
William Blair | Downgraded | Outperform → Market Perform | 2019-10-25 |
Northcoast Research | Downgraded | Buy → Neutral | 2019-10-25 |
Canaccord Genuity | Downgraded | Buy → Hold | 2016-10-28 |
FBR Capital | Reiterated | Outperform | 2016-05-11 |
Stephens & Co. | Downgraded | Overweight → Equal Weight | 2016-04-29 |
Piper Sandler | Downgraded | Overweight → Neutral | 2015-04-24 |
PiperJaffray | Downgraded | Overweight → Neutral | 2015-04-24 |
Pacific Crest | Reiterated | Sector Perform → Perform | 2015-02-19 |
Oppenheimer | Reiterated | Outperform | 2014-12-18 |
Jefferies | Reiterated | Hold | 2014-05-02 |
Morgan Stanley | Reiterated | Equal Weight | 2013-02-21 |
One row per institution, most recent rating